Durvalumab and olaparib combination extends survival in advanced endometrial cancer
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine